Latest Breaking News On - J thorac cardiovasc - Page 1 : comparemela.com

Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study

Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesJ thorac cardiovascClin cardiolColl cardiolSemin thorac cardiovascAjmone marsanEuro heart survey on valvular diseaseAmerican society of echocardiographyValve academic researchCurrent society of thoracic surgeonsSociety for cardiovascular magnetic resonanceFramingham heart studyEuro heart surveyValvular heartThorac cardiovasc surgAmerican college

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting

/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of.

United statesSan antonioJ thorac cardiovascBrian johnston laine morganPat mackinWilson szetoLance berryMeeting of the society thoracic surgeonsGilmartin groupPrnewswire artivion incCardiovascular surgery at penn presbyterian medical centerHealth canadaArtivion incDrug administrationAll cause mortalityPrimary major adverse events

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting

Full IDE Data Set Demonstrates Statistically Significant Reduction of All-Cause Mortality and Primary Major Adverse Events at 30 days with use of AMDS in Acute DeBakey Type I Dissections.

United statesSan antonioJ thorac cardiovascBrian johnston laine morganPat mackinWilson szetoLance berryDrug administrationArtivion incHealth canadaCardiovascular surgery at penn presbyterian medical centerPrnewswire artivion incGilmartin groupMeeting of the society thoracic surgeonsAll cause mortalityPrimary major adverse events

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Sloan ketteringVan coevordenJ thorac cardiovascEuropean society for radiotherapyEuropean organisation for researchClin oncolThorac cardiovasc surgNatl cancer instEuropean societyEuropean organisationCancer resThorac oncolSloan kettering integrated mutation profilingActionable cancer targetsMol diagn

Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its On-X.

United statesCity ofUnited kingdomBrian johnston lynn lewisJ thorac cardiovascColl cardiolD ashley leeInternational normalized ratioGilmartin groupDrug administrationEuropean association for cardioArtivion incPrnewswire artivion incLate breaking science presentedEuropean associationCardio thoracic surgery annual meeting